Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus (HIV). In the current study, we used the mous...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiafen, Brendle, Sarah A., Li, Jingwei J., Walter, Vonn, Cladel, Nancy M., Cooper, Timothy, Shearer, Debra A., Balogh, Karla K., Christensen, Neil D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147738/
https://www.ncbi.nlm.nih.gov/pubmed/35632722
http://dx.doi.org/10.3390/v14050980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147738/
https://www.ncbi.nlm.nih.gov/pubmed/35632722
http://dx.doi.org/10.3390/v14050980

Ejemplares similares